Drug Profile
Research programme: neuraminidase inhibitor - TaiMed Biologics
Alternative Names: Tamiphosphor; TMB-571Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Academia Sinica
- Developer TaiMed Biologics
- Class Small molecules
- Mechanism of Action Neuraminidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza virus infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Influenza-virus-infections in USA (PO)
- 09 Oct 2015 Preclinical development is ongoing in USA
- 28 Dec 2008 Preclinical trials in Influenza virus infections in USA (PO)